Loading…
DBV Technologies S.A. is projected to rise to $25.49 by 2027, a +38% move from its current price of $18.50. DBVT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $18.07 | $18.50 | $18.94 | -0.01% |
| May 30 | $17.89 | $18.50 | $19.13 | -0.01% |
| May 31 | $17.76 | $18.50 | $19.27 | -0.02% |
| Jun 1 | $17.64 | $18.50 | $19.39 | -0.02% |
| Jun 2 | $17.54 | $18.49 | $19.50 | -0.03% |
| Jun 3 | $17.46 | $18.49 | $19.59 | -0.03% |
| Jun 4 | $17.37 | $18.49 | $19.68 | -0.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.37 | $18.49 | $19.68 | -0.04% |
| Week 2 | $16.92 | $18.49 | $20.19 | -0.08% |
| Week 3 | $16.59 | $18.48 | $20.59 | -0.12% |
| Week 4 | $16.30 | $18.47 | $20.93 | -0.16% |
| Week 5 | $16.06 | $18.46 | $21.23 | -0.20% |
| Week 6 | $15.84 | $18.46 | $21.50 | -0.23% |
| Week 7 | $15.64 | $18.45 | $21.76 | -0.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DBV Technologies S.A. is a clinical-stage biopharmaceutical company that focuses on epicutaneous immunotherapy products in France. Its product pipeline includes Viaskin Peanut, which has completed Phase 3 clinical trial for the treatment of peanut allergies, and Viaskin Milk, which is in Phase 1/2 for the treatment of IgE-mediated or cow’s milk protein allergy and eosinophilic esophagitis.
The company’s earlier stage programs include celiac disease, and it develops the Viaskin technology platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A.
was incorporated in 2002 and is headquartered in Châtillon, France.
DBV Technologies S.A. (DBVT) operates in the healthcare sector and is currently priced at $18.18 per share. The stock is ranked 2491 by market position and has a market capitalization of $1.08B. This snapshot places the asset in a niche, higher-risk therapeutic area with a potential long-run upside as the product candidates advance.
A major floor 12.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 15.4% above — a clean break opens room to run.
A major ceiling 32.6% above — clearing it would confirm fresh momentum.
Key DBVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DBVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $18.39 | Buy | $18.47 | Buy |
| MA 10 | $18.83 | Sell | $18.78 | Sell |
| MA 20 | $19.43 | Sell | $19.25 | Sell |
| MA 50 | $20.02 | Sell | $19.86 | Sell |
| MA 100 | $20.57 | Sell | $19.46 | Sell |
| MA 200 | $17.00 | Buy | $17.16 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.27 | Neutral |
| Stoch RSI (14) | 28.61 | Neutral |
| CCI (20) | -91.18 | Neutral |
| Williams %R (14) | -84.55 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | -6.23 | Sell |
| Bollinger %B (20,2) | 0.21 | Neutral |
| Stochastic %K (14) | 15.45 | Buy |
| TRIX (15) | -0.31 | Sell |
| Awesome (5,34) | -1.57 | Sell |
| Ultimate (7,14,28) | 26.34 | Buy |
| Momentum (10) | -1.50 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 18.10 | Buy |
| ADX (14) | 13.69 | Neutral |
| ATR (14) | 0.38 | Info |
The near-term technical picture remains bullish, with RSI(14) at 40 and price drifting around key moving averages. The SMA50 sits at $20.10, while the SMA200 sits at $16.92, providing a constructive backdrop for price action near current levels. Immediate support is at $18.18 and resistance at $22.14, framing a 30-day range of $15.56 to $21.24.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.63 | $18.50 | $25.29 | 0% | Neutral | |
| $20.48 | $25.49 | $33.43 | +38% | Bullish | |
| $23.44 | $29.86 | $40.42 | +61% | Bullish | |
| $28.34 | $36.79 | $51.06 | +99% | Bullish | |
| $31.07 | $41.04 | $58.17 | +122% | Bullish | |
| $31.10 | $41.72 | $60.25 | +125% | Bullish | |
| $35.11 | $47.77 | $70.16 | +158% | Bullish | |
| $38.40 | $52.96 | $78.97 | +186% | Bullish | |
| $45.27 | $63.24 | $95.65 | +242% | Bullish | |
| $53.83 | $76.12 | $116.64 | +311% | Bullish | |
| $70.01 | $104.63 | $169.42 | +466% | Bullish | |
| $145.48 | $238.80 | $419.35 | +11.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $16.63 | $18.50 | $21.76 | +0.00% |
| June 2026 | $15.96 | $18.69 | $22.36 | +1.01% |
| July 2026 | $15.61 | $18.41 | $22.28 | -1.50% |
| August 2026 | $15.90 | $18.85 | $23.03 | +2.43% |
| September 2026 | $16.42 | $19.57 | $24.08 | +3.79% |
| October 2026 | $16.35 | $19.57 | $24.24 | +0.00% |
| November 2026 | $16.27 | $19.55 | $24.36 | -0.09% |
| December 2026 | $16.74 | $20.19 | $25.29 | +3.26% |
Click any year to see its month-by-month DBVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DBVT is projected to trade between $16.63 and $25.29, averaging $18.50 — a potential gain of 0% from today's $18.50. A consolidation phase looks the most probable path here.
DBV Technologies S.A.'s 2027 outlook centres on $25.49, within a $20.48 to $33.43 range. That is up +38% on the projected 2026 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2028, DBVT could reach as high as $40.42, with a base case around $29.86 and support toward $23.44 — roughly +61% from $18.50. Buyers look set to stay in control over this stretch.
Expect DBVT to range from $28.34 to $51.06 through 2029. The $36.79 average target implies a +99% move from current prices. That is up +23% on the projected 2028 average. Momentum favours further upside here.
The DBVT price prediction for 2030 points to an average of $41.04 (low $31.07, high $58.17) — a potential gain of +122% on today's $18.50. Buyers look set to stay in control over this stretch.
In 2031, DBVT is projected to trade between $31.10 and $60.25, averaging $41.72 — a potential gain of +125% from today's $18.50. That is up +2% on the projected 2030 average. Momentum favours further upside here.
DBV Technologies S.A.'s 2032 outlook centres on $47.77, within a $35.11 to $70.16 range. That is up +15% on the projected 2031 average. That marks a +158% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DBVT could reach as high as $78.97, with a base case around $52.96 and support toward $38.40 — roughly +186% from $18.50. Momentum favours further upside here.
Expect DBVT to range from $45.27 to $95.65 through 2034. The $63.24 average target implies a +242% move from current prices. That is up +19% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DBVT price prediction for 2035 points to an average of $76.12 (low $53.83, high $116.64) — a potential gain of +311% on today's $18.50. Momentum favours further upside here.
In 2040, DBVT is projected to trade between $70.01 and $169.42, averaging $104.63 — a potential gain of +466% from today's $18.50. That is up +37% on the projected 2035 average. Buyers look set to stay in control over this stretch.
DBV Technologies S.A.'s 2050 outlook centres on $238.80, within a $145.48 to $419.35 range. That is up +128% on the projected 2040 average. That marks a +11.9x change versus current levels. Momentum favours further upside here.
Investing $1,000 in DBVT today (≈ 54.054054 DBVT) could be worth
$12,907.96
+$11,907.96 (+1191%) by 2050 · US Dollar
Based on the average projected DBVT price of $238.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DBVTwould be worth at today's price.
$1,000 invested in DBVT on May 27, 2025 (≈ 107.642627 DBVT) would be worth
$1,991.39
+$991.39 (+99.1%) today · 1.99× · US Dollar
Based on a DBVT entry price of $9.29 vs. today's $18.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.54 | $997.84 | -0.2% |
| 1 month ago | $20.39 | $907.31 | -9.3% |
| 3 months ago | $21.52 | $859.67 | -14.0% |
| 6 months ago | $13.09 | $1,413.29 | +41.3% |
| 1 year ago | $9.29 | $1,991.39 | +99.1% |
| All time (5.0y) ago | $11.54 | $1,603.12 | +60.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DBVT forecast.
Our base-case forecast reaches $37.00 around 2030.
Implied market cap at $37.00: $2.19B
The multi-year forecast shows a bullish trajectory beyond 2026, with the 2026 average price at $18.18 (min $16.63, max $25.28) and a neutral stance. By 2027, the average climbs to $25.75 with a 41.6% ROI and bullish sentiment, and it extends through 2028 ($30.62 avg, 68.4% ROI) and 2029 ($38.10 avg, 109.6% ROI). By 2030, the average is $42.58 with a 134.2% ROI and bullish sentiment.
The forecast continues to 2031 ($43.76 avg, 140.7% ROI), 2032 ($50.85 avg, 179.7% ROI), and 2033 ($56.76 avg, 212.2% ROI), then accelerates further to 2034 ($68.52 avg, 276.9% ROI) and 2035 ($82.77 avg, 355.3% ROI). The long-range projections reach $116.81 average by 2040 (542.5% ROI) and $269.95 average by 2050 (1384.9% ROI), with bullish sentiment throughout. These figures are estimates, not guarantees, and reflect differing assumed paths for the asset’s price.
Tap a question to reveal the answer.
Avg $42.58, min $32.24, max $60.39, ROI 134.2%, sentiment BULLISH.
Forecast shows bullish sentiment from 2027 onward with rising averages and ROIs; 2026 is neutral with avg $18.18 and ROI 0. These are estimates, not guarantees.
The forecast's max for 2040 is $189.18, which is below $200.
Current price is $18.18 and market cap is $1.08B.
Low $15.56 and high $21.24.
DBV Technologies S.A. Community Discussion
0Share your DBV Technologies S.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.